Name: UMIN ID:
Unique ID issued by UMIN | UMIN000012903 |
---|---|
Receipt number | R000015079 |
Scientific Title | Randomized phase II study of nab-Paclitaxel (nab-PTX) plus Carboplatin(CBDCA) followed by maintenance nab-PTX or TS-1 plus CBDCA followed by maintenance TS-1 as first-line treatment in patients with stage IIIB/IV squamous cell carcinoma of the lung. |
Date of disclosure of the study information | 2014/02/01 |
Last modified on | 2018/10/24 11:02:31 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/01/20 10:31:30 | ||
2 | Update | 2015/08/14 12:42:22 | Organization Organization Division name Division name Address Address TEL Organization Organization Division name Division name Address Address TEL Organization Organization Division name Division name Address Address TEL Institute Institute Email1 |
|
3 | Update | 2018/10/24 11:02:31 | Recruitment status |